Literature DB >> 30067582

Exploration of Relationships Between Postoperative Pain and Subsyndromal Delirium in Older Adults.

Dawn L Denny1, Tami L Such.   

Abstract

BACKGROUND: Subsyndromal delirium is associated with serious adverse outcomes of longer lengths of stay, increased long-term care admissions, and higher 6-month mortality rates. Postoperative pain is a risk factor for delirium, but the relationship between pain and the severity of subclinical delirium symptoms is unclear. A better understanding will inform nursing interventions to reduce adverse outcomes associated with delirium symptoms.
OBJECTIVES: The purpose of this correlational study was to determine the relationship between pain and subsyndromal delirium in older adults following joint replacement surgery.
METHODS: Delirium assessments were completed on postoperative Days 1, 2, and 3 for 49 adults of ages 65 years or older following joint replacement surgery. Multiple linear regression was used to analyze data for relationships between postoperative pain and subsyndromal delirium and, secondarily, postoperative opioid intake and subsyndromal delirium while accounting for known preoperative risk factors.
RESULTS: Increased age, cognitive impairment, current smoking, and higher levels of self-reported pain were significantly related to subsyndromal delirium (p < .001). After accounting for preoperative risk factors of age, cognitive status, smoking status, and opioid intake, pain was significantly related to subsyndromal delirium (β = .28, p < .05); however, opioid intake did not contribute to subsyndromal delirium. DISCUSSION: Higher pain levels were significantly related to subsyndromal delirium when age, cognitive status, smoking status, and opioid intake were accounted for (p < .05), although opioid intake was not significantly related to subsyndromal delirium after accounting for age, cognitive status, smoking status, and pain. Nurses caring for older adults who undergo joint replacement surgery are encouraged to ensure effective pain management to reduce onset and severity of delirium symptoms.

Entities:  

Mesh:

Year:  2018        PMID: 30067582     DOI: 10.1097/NNR.0000000000000305

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  5 in total

1.  Impact of dexmedetomidine supplemented analgesia on delirium in patients recovering from orthopedic surgery: A randomized controlled trial.

Authors:  Hong Hong; Da-Zhi Zhang; Mo Li; Geng Wang; Sai-Nan Zhu; Yue Zhang; Dong-Xin Wang; Daniel I Sessler
Journal:  BMC Anesthesiol       Date:  2021-09-13       Impact factor: 2.217

2.  The Age-adjusted Charlson Comorbidity Index predicts post-operative delirium in the elderly following thoracic and abdominal surgery: A prospective observational cohort study.

Authors:  Jing Liu; Jianli Li; Jinhua He; Huanhuan Zhang; Meinv Liu; Junfang Rong
Journal:  Front Aging Neurosci       Date:  2022-08-17       Impact factor: 5.702

3.  Delirium in Internal Medicine Departments in a Tertiary Hospital in Israel: Occurrence, Detection Rates, Risk Factors, and Outcomes.

Authors:  Nirit Tzur Efraim; Evgeniya Zikrin; David Shacham; Dori Katz; Evgeni Makulin; Leonid Barski; Lior Zeller; Carmi Bartal; Tamar Freud; Svetlana Lebedinski; Yan Press
Journal:  Front Med (Lausanne)       Date:  2020-10-19

4.  Comparison of Bispectral Index-Guided Individualized Anesthesia with Standard General Anesthesia on Inadequate Emergence and Postoperative Delirium in Elderly Patients Undergoing Esophagectomy: A Retrospective Study at a Single Center.

Authors:  Yichen Yang; Chengjun Song; Chengwei Song; Chengwen Li
Journal:  Med Sci Monit       Date:  2020-10-01

5.  Ultrasound-guided continuous thoracic paravertebral block alleviates postoperative delirium in elderly patients undergoing esophagectomy: A randomized controlled trial.

Authors:  Liang Jin; Rui Yao; Lei Heng; Bo Pang; Fu-Guo Sun; Ying Shen; Jun-Feng Zhong; Pan-Pan Zhao; Cong-You Wu; Bei-Ping Li
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.